IC4 - Acute and chronic thromboembolism Flashcards

1
Q

What are the three components in the Virchow’s Triad?

A

1.Hypercoaguation
2.Vascular damage
3.Circulatory Stasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss the development of VTE disorder, ACS, AIS.

A

When thrombi is formed (usually above knee sources), the thrombi can move in the blood circulation and deposit in the vein, blocking blood flow and impair gaseous exchange to organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of DVT?

A
  1. Leg swelling, pain, warmth which are usually unilateral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs of DVT includes _______ superficial veins (palpable cord) and _____ in back of knee when foot is dorsiflex (Homan’s sign).

A

dilated, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are symptoms of pulmonary embolism?

A

Respiratory symptoms like cough, SOB, chest tightness, palpitation. Dizziness or light headedness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the signs of PE?

A

Tachypnea, tachycardia, diaphoretic. In massive PE, hypotension, hypoxic, cyanotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is suspected DVT diagnosed?

A

Use of Wells-DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two 2 possible DVT?

A
  1. Distal (below knee)
  2. Proximal (above knee)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Distal DVT requires initiation of ______ or ______.

A

anticoagulant, surveillance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the plan for diagnosed proximal DVT ?

A

Anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

For patients with wells-DVT score less than 2, what is the next step that the HCP should undertake?

A

Test for D-dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is released when fibrin mesh is degraded?

A

D-dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

D-dimer have good _____ predictive value.

A

Negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When D-dimer value is positive, it is _______ that patient has DVT.

A

not confirmed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is PE diagnosed?

A

Wells criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patient with a score of less than or equal to 4 for PE well score should be examined for ______.

A

D -dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should thrombolytic therapy followed by anticoagulation with UFH or LMWH be started?

A
  1. PE with severe cardiopulmonary compromise
  2. DVT with high risk of limb loss
18
Q

For patients hospitalised for VTE treatment, when is UFH/low dose LMWH and warfarin treatment (INR>2) given?

A

CrCl < 30ml/min

19
Q

How is decision to continue anticoagulant for VTE made?

A

Look at risk factors and determine if it is transient, provoked or chronic.

20
Q

What are factors favoring use of warfarin?

A
  1. May be used in renal impaired
  2. Reliable measurement assay
  3. Effects of drug interaction can be monitored
21
Q

What are factors favoring DOACs?

A
  1. Fixed dosing no need titrate
  2. Lesser DDI than warfarin
  3. Only dabigatran has initial parental agent
22
Q

What are the two viable options for VTE if patient has CrCl of less than 30ml/min?

A
  1. Warfarin overlapping with UFH
  2. Warfarin overlapping with dose reduced enoxaparin
23
Q

How long is the treatment of VTE with oral anticoagulant?

A

90 days

24
Q

Why do low MW heparin have lesser inhibitory activity against thrombin?

A

Formation of a ternary heparin antithrombin-thrombin complex requires at 18 saccharine units whcih LMWH does not have

25
Q

What factors does -xaban targets?

A

Xa (10a)

26
Q

What factor does -gatran target?

A

IIa

27
Q

What is the factors that warfarin target?

A

2,7,9,10

28
Q

Which DOACs require parental anticoagulants?

A

Dabigatran (IV>=5d then 150mg BD)
Edoxaban (IV>=5d then 60mg/d)

29
Q

Edoxaban is not recommended in patients with CrCl > _____ml/min.

A

95

30
Q

How is rivaroxaban dosed?

A

15mgBD for 3 weeks followed by 20mg/day for 3 to 6 months then 10mg OM

31
Q

How is apixaban dosed?

A

10mg BD x 7 days followed by 5mg BD 6 months then 2.5mg BD

32
Q

What is the thrombolytic used in VTE?

A

Alteplase

33
Q

How can PE be treated in low to intermediate risk patients?

A
  1. Drug of choice if need: LMWH or fondaparinux
  2. If require VKA, overlap with LMHW till INR is 2.5
34
Q

Which group of VTE patients should not be given DOACs?

A
  1. Severe renal impairment
  2. Pregnant and lactation
  3. Antiphospholipid antibody syndrome
35
Q

How are high risk patients treated for PE?

A
  1. Anticoagulant + UFH
  2. Systemic thrombolytic therapy
36
Q

Rescue thrombolytic treatment is recommended if patient is ________ on AC treatment.

A

deteriorating hemodynamically

37
Q

Common thrombolytics used for reperfusion in PE is ____.

A

rtPA

38
Q

Patients with antiphospholipid antibody syndrome should be given _______ oral anticoagulant VKA.

A

indefinite

39
Q

What is the drug of choice for treating VTE in pregnant women?

A

LMWH (1.0mg/kg BD SQ)

40
Q

Enoxaparin dose is reduced in ______ patients.

A

severely renal impaired (<30mL/mins)

41
Q

VTE prophylaxes is given after ___ months.

A

3 to 6